Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells. [electronic resource]
Producer: 20140127Description: 218-30 p. digitalISSN:- 1949-2553
- Alpha Particles -- therapeutic use
- Antigens, CD20 -- immunology
- Apoptosis -- radiation effects
- Bismuth -- pharmacology
- Caspases -- metabolism
- Cell Cycle -- radiation effects
- Down-Regulation
- Drug Resistance, Neoplasm
- HL-60 Cells
- Humans
- Immunotoxins -- immunology
- Lymphoma, Non-Hodgkin -- genetics
- Radiation Tolerance
- Radioimmunotherapy -- methods
- Radioisotopes -- pharmacology
- Signal Transduction
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.